{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:40:52Z","timestamp":1788273652920,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.josat.2025.209705","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T02:41:07Z","timestamp":1746240067000},"page":"209705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Role of ketamine in the treatment of substance use disorders: A systematic review"],"prefix":"10.1016","volume":"175","author":[{"given":"Reinhard","family":"Janssen-Aguilar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakila","family":"Meshkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Demchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Greenshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Tanguay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah M.","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Swainson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Jetly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkat","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2025.209705_bb0005","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association (APA)","year":"2022"},{"issue":"2","key":"10.1016\/j.josat.2025.209705_bb0010","doi-asserted-by":"crossref","first-page":"S346","DOI":"10.1016\/j.ajog.2020.12.569","article-title":"Use of ketamine infusion in post cesarean pain management in patients with opioid use disorder","volume":"224","author":"Andrinas","year":"2021","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1016\/j.josat.2025.209705_bb0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/00952990.2020.1808982","article-title":"Ketamine-facilitated behavioral treatment for cannabis use disorder: A proof of concept study","volume":"47","author":"Azhari","year":"2021","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2025.209705_bb0020","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neubiorev.2017.03.010","article-title":"Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis","volume":"77","author":"Bartoli","year":"2017","journal-title":"Neuroscience & Biobehavioral Reviews"},{"key":"10.1016\/j.josat.2025.209705_bb0025","series-title":"Substance use and addiction research","first-page":"147","article-title":"Misuse and addiction definitions, demographics, and general concepts","author":"Chen","year":"2023"},{"key":"10.1016\/j.josat.2025.209705_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.672526","article-title":"Ketamine: neuroprotective or neurotoxic?","volume":"15","author":"Choudhury","year":"2021","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.josat.2025.209705_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1283733","article-title":"Use of ketamine for treatment resistant depression: Updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta, Canada","volume":"14","author":"Chrenek","year":"2024","journal-title":"Frontiers in Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2025.209705_bb0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/mp.2016.39","article-title":"Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: A randomized, crossover trial","volume":"22","author":"Dakwar","year":"2017","journal-title":"Molecular Psychiatry"},{"issue":"2","key":"10.1016\/j.josat.2025.209705_bb0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1176\/appi.ajp.2019.19070684","article-title":"A single ketamine infusion combined with motivational enhancement therapy for alcohol use disorder: A randomized midazolam-controlled pilot trial","volume":"177","author":"Dakwar","year":"2020","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2025.209705_bb0050","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biopsych.2013.08.009","article-title":"The effects of subanesthetic ketamine infusions on motivation to quit and cue-induced craving in cocaine-dependent research volunteers","volume":"76","author":"Dakwar","year":"2014","journal-title":"Biological Psychiatry"},{"issue":"11","key":"10.1016\/j.josat.2025.209705_bb0055","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1176\/appi.ajp.2019.18101123","article-title":"A single ketamine infusion combined with mindfulness-based behavioral modification to treat cocaine dependence: A randomized clinical trial","volume":"176","author":"Dakwar","year":"2019","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1016\/j.josat.2025.209705_bb0060","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/add.15647","article-title":"Clinical management of the alcohol withdrawal syndrome","volume":"117","author":"Day","year":"2022","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.josat.2025.209705_bb0065","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3390\/ijerph15061083","article-title":"Alcoholism: A multi-systemic cellular insult to organs","volume":"15","author":"Dguzeh","year":"2018","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"1","key":"10.1016\/j.josat.2025.209705_bb0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuropharm.2011.08.044","article-title":"Signaling pathways underlying the rapid antidepressant actions of ketamine","volume":"62","author":"Duman","year":"2012","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.josat.2025.209705_bb0075","article-title":"Ketamine in chronic pain: A review","volume":"16","author":"Fa\u00edsco","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.josat.2025.209705_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1141836","article-title":"The therapeutic use and efficacy of ketamine in alcohol use disorder and alcohol withdrawal syndrome: A scoping review","volume":"14","author":"Goldfine","year":"2023","journal-title":"Frontiers in Psychiatry"},{"issue":"7","key":"10.1016\/j.josat.2025.209705_bb0085","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.21037\/jtd.2017.06.104","article-title":"Role of cannabis in cardiovascular disorders","volume":"9","author":"Goyal","year":"2017","journal-title":"Journal of Thoracic Disease"},{"issue":"2","key":"10.1016\/j.josat.2025.209705_bb0090","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1176\/appi.ajp.2021.21030277","article-title":"Adjunctive ketamine with relapse prevention\u2013based psychological therapy in the treatment of alcohol use disorder","volume":"179","author":"Grabski","year":"2022","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.josat.2025.209705_bb0095","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.2147\/NDT.S117146","article-title":"Efficacy of ketamine in the rapid treatment of major depressive disorder: A meta-analysis of randomized, double-blind, placebo-controlled studies","author":"Han","year":"2016","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"10.1016\/j.josat.2025.209705_bb0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.alcohol.2019.08.005","article-title":"Correlations between subunits of GABAA and NMDA receptors after chronic alcohol treatment or withdrawal, and the effect of taurine in the hippocampus of rats","volume":"82","author":"Hansen","year":"2020","journal-title":"Alcohol"},{"issue":"4, Suppl","key":"10.1016\/j.josat.2025.209705_bb6010","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.annemergmed.2022.08.183","article-title":"159 Ketamine use for buprenorphine-precipitated opioid withdrawal: A case series of 10 patients","volume":"80","author":"Heeney","year":"2022","journal-title":"Annals of Emergency Medicine"},{"issue":"1","key":"10.1016\/j.josat.2025.209705_bb0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/02698811241303597","article-title":"Is there a risk of addiction to ketamine during the treatment of depression? A systematic review of available literature","volume":"39","author":"Ingrosso","year":"2025","journal-title":"Journal of Psychopharmacology"},{"issue":"4","key":"10.1016\/j.josat.2025.209705_bb6000","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0740-5472(02)00275-1","article-title":"Ketamine psychotherapy for heroin addiction: Immediate effects and two-year follow-up","volume":"23","author":"Krupitsky","year":"2002","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2025.209705_bb6005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/02791072.2007.10399860","article-title":"Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence","volume":"39","author":"Krupitsky","year":"2007","journal-title":"Journal of Psychoactive Drugs"},{"issue":"1","key":"10.1016\/j.josat.2025.209705_bb0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41386-023-01629-w","article-title":"Ketamine and rapid antidepressant action: New treatments and novel synaptic signaling mechanisms","volume":"49","author":"Krystal","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.josat.2025.209705_bb0120","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jpsychires.2022.04.035","article-title":"The abuse liability of ketamine: A scoping review of preclinical and clinical studies","volume":"151","author":"Le","year":"2022","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.josat.2025.209705_bb0125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainresbull.2016.05.016","article-title":"Ketamine abuse potential and use disorder","volume":"126","author":"Liu","year":"2016","journal-title":"Brain Research Bulletin"},{"issue":"13","key":"10.1016\/j.josat.2025.209705_bb0130","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2025.209705_bb0135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jad.2013.11.014","article-title":"A review of ketamine in affective disorders: Current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action","volume":"156","author":"Naughton","year":"2014","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1016\/j.josat.2025.209705_bb0140","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu039","article-title":"Ketamine\u2019s antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder","volume":"18","author":"Niciu","year":"2015","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.josat.2025.209705_bb0145","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.josat.2025.209705_bb0150","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/add.14234","article-title":"Global statistics on alcohol, tobacco and illicit drug use: 2017 status report","volume":"113","author":"Peacock","year":"2018","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.josat.2025.209705_bb0155","doi-asserted-by":"crossref","first-page":"e768","DOI":"10.1097\/CCM.0000000000003204","article-title":"Adjunct ketamine use in the management of severe ethanol withdrawal","volume":"46","author":"Pizon","year":"2018","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.josat.2025.209705_bb0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/SAR.S337338","article-title":"Cocaine use disorder (CUD): Current clinical perspectives","author":"Schwartz","year":"2022","journal-title":"Substance Abuse and Rehabilitation"},{"key":"10.1016\/j.josat.2025.209705_bb0165","author":"Scottish Intercollegiate Guidelines Network (SIGN)"},{"key":"10.1016\/j.josat.2025.209705_bb0170","author":"Scottish Intercollegiate Guidelines Network (SIGN)"},{"issue":"5","key":"10.1016\/j.josat.2025.209705_bb0175","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2174\/1570159X12666140619204251","article-title":"The role of ketamine in treatment-resistant depression: A systematic review","volume":"12","author":"Serafini","year":"2014","journal-title":"Current Neuropharmacology"},{"issue":"4","key":"10.1016\/j.josat.2025.209705_bb0180","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/YCO.0000000000000337","article-title":"Sex differences in prescription opioid use","volume":"30","author":"Serdarevic","year":"2017","journal-title":"Current Opinion in Psychiatry"},{"key":"10.1016\/j.josat.2025.209705_bb0185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13181-018-0662-8","article-title":"Adjunctive use of ketamine for benzodiazepine-resistant severe alcohol withdrawal: A retrospective evaluation","volume":"14","author":"Shah","year":"2018","journal-title":"Journal of Medical Toxicology"},{"key":"10.1016\/j.josat.2025.209705_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2019.105946","article-title":"Gender differences in prescription opioid use and misuse: Implications for men\u2019s health and the opioid epidemic","volume":"131","author":"Silver","year":"2020","journal-title":"Preventive Medicine"},{"issue":"7922","key":"10.1016\/j.josat.2025.209705_bb0195","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41586-022-04993-7","article-title":"Dual action of ketamine confines addiction liability","volume":"608","author":"Simmler","year":"2022","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.josat.2025.209705_bb0200","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/jcpt.12497","article-title":"What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities","volume":"42","author":"Strasburger","year":"2017","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"10.1016\/j.josat.2025.209705_bb0205","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)"},{"issue":"3","key":"10.1016\/j.josat.2025.209705_bb0210","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40263-022-00897-2","article-title":"Non-parenteral ketamine for depression: A practical discussion on addiction potential and recommendations for judicious prescribing","volume":"36","author":"Swainson","year":"2022","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.josat.2025.209705_bb0215","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13722-022-00345-y","article-title":"Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: Pilot trial feasibility and readmission rates","volume":"17","author":"Terasaki","year":"2022","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2025.209705_bb0220","author":"The National Institutes of Health (NIH)"},{"issue":"2","key":"10.1016\/j.josat.2025.209705_bb0225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1176\/appi.ajp.2019.19121284","article-title":"Personalizing the treatment of substance use disorders","volume":"177","author":"Volkow","year":"2020","journal-title":"American Journal of Psychiatry"},{"issue":"9904","key":"10.1016\/j.josat.2025.209705_bb0230","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010","volume":"382","author":"Whiteford","year":"2013","journal-title":"The Lancet"},{"issue":"7","key":"10.1016\/j.josat.2025.209705_bb0235","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/s41386-019-0317-8","article-title":"Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant","volume":"44","author":"Wilkinson","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.josat.2025.209705_bb0240","first-page":"457","article-title":"Medications for alcohol use disorder","volume":"93","author":"Winslow","year":"2016","journal-title":"American Family Physician"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925000840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925000840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T18:53:25Z","timestamp":1749581605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875925000840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":50,"alternative-id":["S2949875925000840"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209705","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of ketamine in the treatment of substance use disorders: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209705"}}